Keymed Biosciences Inc. held its Annual General Meeting on June 26, 2025. During the meeting, several proposals were presented and approved. These included the re-election of Dr. Bo Chen, Dr. Changyu Wang, and Dr. Gang Xu as executive directors, and the re-election of Mr. Qi Chen, Dr. Min Chuan Wang, and Mr. Yilun Liu as non-executive directors. Additionally, Prof. Xiao-Fan Wang, Prof. Yang Ke, and Mr. Cheuk Kin Stephen Law were re-elected as independent non-executive directors. All proposals were passed by shareholders as ordinary resolutions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.